Oklahoma Workers' Comp Opt-Out Aftermath and Pharmacy Lien Strategy

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 26, 2026 | 7 min read

Oklahoma's workers' compensation system — reshaped after the opt-out controversy and 2013 reforms — creates pharmacy coverage gaps that pharmacy liens fill in dual-claim PI cases. This guide covers OK dual-claim strategy for PI attorneys.

Oklahoma's workers' compensation system underwent significant upheaval with the 2013 Administrative Workers' Compensation Act (AWCA) and the subsequent legal battles over employer opt-out provisions. The Oklahoma Supreme Court struck down the opt-out framework in 2016, but the reformed system that remains still creates pharmacy coverage gaps — particularly in dual-claim cases where a third-party tortfeasor contributes to a workplace injury. A pharmacy lien against the PI settlement fills these gaps when workers' comp falls short.

• Oklahoma's AWCA (85A O.S. § 1-101 et seq.) reformed the comp system in 2013, and the 2016 Supreme Court decision in Vasquez v. Dillard's struck down the employer opt-out provision — but the remaining reformed system still uses restrictive treatment guidelines and formulary controls
• Third-party PI claims under 85A O.S. § 43 create parallel recovery opportunities where pharmacy liens cover medications that comp carriers deny under the reformed system's restrictive guidelines
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every Oklahoma case, providing pharmacist-signed documentation that supports pharmacy lien amounts at settlement
• According to James Wong, PharmD, founder of LienScripts, "Oklahoma's post-reform comp system is more restrictive than the pre-2013 framework — treatment guidelines give carriers more ammunition to deny medications, and LienScripts fills the gap for dual-claim patients"
• Oklahoma follows modified comparative negligence with a 51% bar under 23 O.S. § 13, and pharmacy lien documentation strengthens special damages for plaintiffs under the fault threshold

Oklahoma's Post-Reform Workers' Comp Landscape

The 2013 AWCA replaced Oklahoma's prior workers' compensation framework with an administrative system overseen by the Workers' Compensation Commission. The reform introduced several changes that directly affect pharmacy benefits:

Official Treatment Guidelines (ODG): Oklahoma adopted the Official Disability Guidelines (ODG) as the benchmark for treatment decisions. Comp carriers use ODG to evaluate medical necessity, and medications outside ODG recommendations are subject to heightened scrutiny and frequent denials.

Closed drug formulary provisions: The reformed system gave comp carriers greater authority to restrict medications to approved formulary lists, with prior authorization required for non-formulary drugs.

Independent medical examinations (IMEs): The AWCA expanded the use of carrier-requested IMEs, which frequently result in treatment plan modifications that reduce or eliminate prescribed medications.

The opt-out aftermath: Although the Oklahoma Supreme Court struck down the opt-out provision — which had allowed large employers to create their own benefit plans outside the comp system — the remaining AWCA framework retained the restrictive treatment guidelines and formulary controls that affected pharmacy access.

[!KEY] Oklahoma's post-2013 AWCA framework gives comp carriers extensive control over medication approvals through ODG treatment guidelines — medications outside these guidelines face automatic denial, creating predictable pharmacy lien opportunities in dual-claim cases.

Third-Party Claims and the Pharmacy Lien Opportunity

Oklahoma's exclusive remedy doctrine under the AWCA bars employees from suing employers for workplace injuries. However, 85A O.S. § 43 preserves the right to pursue a civil action against any third party whose negligence contributed to the injury.

Common dual-claim scenarios in Oklahoma:

• An oil field worker struck by a third-party contractor's vehicle on a well site — comp covers the employer, PI runs against the negligent contractor
• A Tulsa warehouse employee injured by defective equipment from a third-party manufacturer — comp covers the employer, product liability runs against the maker
• An Oklahoma City truck driver rear-ended by a negligent motorist during a delivery — comp covers the employer, PI runs against the at-fault driver
• A construction worker injured on a highway project by a passing driver's negligence — comp covers the contractor, tort runs against the motorist

In each case, the comp carrier covers authorized medications while the pharmacy lien covers medications denied under the reformed system's restrictive guidelines.

Where ODG Guidelines Create Coverage Gaps

The ODG treatment guidelines create specific, predictable gaps in Oklahoma comp coverage:

Pain management restrictions: ODG limits opioid treatment duration and dosage, requires step therapy with NSAIDs and muscle relaxants before authorizing stronger medications, and mandates tapering protocols. Patients with severe injuries who need sustained pain management frequently exceed ODG parameters.

Compound medication exclusions: ODG generally does not support compound topical preparations, which many comp carriers use as grounds for blanket denial of all compound prescriptions regardless of clinical appropriateness.

Psychiatric medication limitations: ODG provides limited support for psychiatric medications (anxiolytics, antidepressants, sleep aids) in comp claims, and carriers routinely deny these by arguing the psychological condition is not directly caused by the industrial injury.

Duration limits: ODG establishes treatment duration benchmarks that carriers use to cut off medication coverage after a specified period, regardless of the patient's ongoing clinical needs.

[!TIP] When an Oklahoma comp carrier denies a medication citing ODG guidelines, request the specific ODG reference — many denials cite ODG generically without identifying which guideline applies, and a specific citation challenge can overturn the denial or, at minimum, strengthen the pharmacy lien's necessity documentation.

Workers' Comp Subrogation Under 85A O.S. § 43

Under the AWCA, the employer or comp carrier has a subrogation right against third-party PI recoveries. The carrier can recover benefits paid from the PI settlement, including medical expenses and indemnity benefits.

Oklahoma's subrogation framework requires the carrier's recovery to be reduced by a proportionate share of attorney fees and costs — the fee credit that creates room for the pharmacy lien in the settlement distribution.

[!KEY] Oklahoma's comp subrogation under 85A O.S. § 43 competes with the pharmacy lien for PI settlement proceeds — apply the statutory attorney fee credit to the carrier's subrogation first, then address pharmacy lien resolution with the remaining funds.

Attorney Strategy for Oklahoma Dual-Claim Cases

Map ODG restrictions at case intake: Review the client's prescribed medications against ODG guidelines to identify which prescriptions the comp carrier will likely deny. Begin pharmacy lien coordination for anticipated denials before the denial arrives.

Challenge vague ODG citations: Comp carriers in Oklahoma frequently deny medications with generic references to ODG guidelines without specifying which recommendation applies. Challenge these denials — the specificity requirement can overturn the denial or create a documented denial record that supports the pharmacy lien.

Use MERIT to counter ODG-based defense arguments: As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "Oklahoma adjusters often argue that ODG guidelines prove the medication was unnecessary. The MERIT report provides the clinical counter-narrative — pharmacist-documented medical necessity, prescriber rationale, and patient-specific factors that ODG guidelines cannot account for."

Negotiate comp subrogation with fee credit: Apply the statutory attorney fee credit to reduce the comp carrier's subrogation recovery. This is the most effective tool for creating settlement room for the pharmacy lien and client recovery.

Build the demand to reflect post-reform realities: Oklahoma's reformed comp system leaves more medications uncovered than the pre-2013 framework did. The PI demand should reflect the full pharmacy lien amount as a distinct special damage, with MERIT documentation supporting each charge.

Frequently Asked Questions